FERRARI, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 1.671
AS - Asia 1.222
EU - Europa 991
AF - Africa 88
Continente sconosciuto - Info sul continente non disponibili 57
SA - Sud America 51
Totale 4.080
Nazione #
US - Stati Uniti d'America 1.653
SG - Singapore 401
VN - Vietnam 292
GB - Regno Unito 266
CN - Cina 265
IT - Italia 158
DE - Germania 151
SE - Svezia 116
HK - Hong Kong 111
FR - Francia 74
RU - Federazione Russa 65
IN - India 56
IE - Irlanda 47
BR - Brasile 31
JP - Giappone 31
CI - Costa d'Avorio 30
ZA - Sudafrica 30
EE - Estonia 25
BD - Bangladesh 20
TG - Togo 20
CH - Svizzera 17
FI - Finlandia 16
UA - Ucraina 16
AR - Argentina 9
BE - Belgio 9
CA - Canada 9
JO - Giordania 8
NL - Olanda 8
EC - Ecuador 7
PH - Filippine 7
BG - Bulgaria 6
PL - Polonia 5
TH - Thailandia 5
ES - Italia 4
IQ - Iraq 4
KR - Corea 4
MX - Messico 4
PK - Pakistan 3
TR - Turchia 3
AL - Albania 2
AT - Austria 2
CO - Colombia 2
CR - Costa Rica 2
ET - Etiopia 2
EU - Europa 2
SY - Repubblica araba siriana 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BY - Bielorussia 1
CL - Cile 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
ID - Indonesia 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
MA - Marocco 1
MM - Myanmar 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
SA - Arabia Saudita 1
SC - Seychelles 1
SN - Senegal 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.026
Città #
Singapore 277
Southend 246
Ashburn 188
Fairfield 168
Chandler 156
Hong Kong 108
Woodbridge 96
San Jose 95
Hanoi 87
Santa Clara 80
Wilmington 77
Ho Chi Minh City 69
Houston 68
Seattle 60
Ann Arbor 55
Princeton 52
Beijing 49
Dublin 47
Boardman 45
Cambridge 41
Abidjan 30
Nanjing 28
Tokyo 28
Turin 28
Lauterbourg 27
Padova 27
Los Angeles 26
Westminster 25
Bologna 22
Council Bluffs 22
Dearborn 22
Bremen 21
Lomé 20
Medford 15
Saint Petersburg 15
Bern 14
Frankfurt am Main 13
Nanchang 13
San Diego 13
Helsinki 12
Falls Church 11
Munich 11
Berlin 10
Changsha 10
Haiphong 10
Brussels 9
Jinan 9
New York 9
Redondo Beach 9
Amman 8
Buffalo 8
Da Nang 8
Dallas 8
Hangzhou 8
Hebei 8
Catanzaro 6
Düsseldorf 6
Milan 6
Shenyang 6
Redwood City 5
Zhengzhou 5
Biên Hòa 4
Denver 4
Falkenstein 4
Guangzhou 4
Haikou 4
Jiaxing 4
Ningbo 4
Quận Bình Thạnh 4
Shanghai 4
Sofia 4
Taizhou 4
Toronto 4
Turku 4
Atlanta 3
Bắc Giang 3
Frattamaggiore 3
Guayaquil 3
Harbin 3
Moscow 3
Naples 3
Rome 3
Stockholm 3
São Paulo 3
Tianjin 3
Tân Tiến 3
Vĩnh Long 3
Warsaw 3
Wuppertal 3
Điện Bàn 3
Addis Ababa 2
Amsterdam 2
Barcelona 2
Barletta 2
Bexley 2
Brooklyn 2
Bühl 2
Bến Tre 2
Can Tho 2
Charlotte 2
Totale 2.775
Nome #
Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1 218
Ewing sarcoma in patients over 40 years of age: A prospective analysis of 31 patients treated at a single institution 201
Chemotherapy-related toxicity in patients with non-metastatic Ewing sarcoma: influence of sex and age 185
Does MGMT (O6-methylguanine–DNA methyltransferase) have a role in metastatic Ewing sarcoma (ES) patients (pts) undergoing temozolomide (TMZ) and irinotecan (IRI)? 183
Response to high-dose ifosfamide in patients with advanced/recurrent ewing sarcoma 181
Emerging therapeutic targets for synovial sarcoma 173
Extraskeletal myxoid chondrosarcoma: A retrospective analysis of 69 patients with localized disease and molecularly confirmed diagnosis. 167
High dose ifosfamide in metastatic high-grade osteosarcoma, after failure of standard multimodal chemotherapy. 167
Immune-infiltrate characterization in localized osteosarcoma patients treated within protocol ISG-OS1. 162
A nonrandomized phase II trial of sorafenib (S) and everolimus (E) in unresectable metastatic osteosarcoma (OST) patients (pts) relapsed after standard chemotherapy. 161
Feasibility of preoperative chemotherapy with or without radiation therapy in localized soft tissue sarcomas of limbs and superficial trunk in the Italian sarcoma group/grupo español de investigación en sarcomas randomized clinical trial: Three versus five cycles of full-dose epirubicin plus ifosfamide 155
Periosteal osteosarcoma: a single-institution experience. 154
A four-arm randomized phase II trial with NGR-hTNF given at low or high dose with or without doxorubicin in soft tissue sarcomas (STS). 150
Primary Angiosarcoma of Bone: A Retrospective Analysis of 60 Patients From 2 Institutions 146
Long-term treatment of giant cell tumors of bone (GCTB) with denosumab: a two institutions 8-year experience. 145
Neoadjuvant denosumab treatment of locally advanced giant cell tumor of bone (GCTB). 144
High-grade bone sarcomas with synchronous metastases in patients older than 40. Results of the European Bone over 40: Sarcoma Study (EURO.B.O.S.S.) 142
Temozolamide and irinotecan in metastatic Ewing sarcoma: An Italian Sarcoma Group and Royal Marsden Hospital join study. 141
FDG PET/CT IN PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY FOR LOCALIZED BONE SARCOMAS 138
PD1 and PDL1 expression, tumoral microenvironment (TME) characterization and clinical implication in localized osteosarcoma 134
Gemcitibine (G) and docetaxel (D) in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy. 133
International single-arm phase II trial of pazopanib in advanced extraskeletal myxoid chondrosarcoma: A Collaborative Spanish (GEIS), Italian (ISG) and French (FSG) Sarcoma Groups study. 130
EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma 129
A phase 1b trial with the combination of trabectedin and olaparib in relapsed patients (pts) with advanced and unresectable bone and soft tissue sarcomas (BSTS): An Italian sarcoma group (ISG) study. 127
Imaging in bone sarcomas. the chemotherapist's point of view 123
MRgFUS new applications in musculoskeletal pathology: a miscellaneous case review 99
null 92
Totale 4.080
Categoria #
all - tutte 11.069
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.069


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022374 0 0 30 17 60 27 5 22 24 23 78 88
2022/2023581 58 90 27 76 47 41 23 31 112 14 26 36
2023/2024106 7 21 11 3 6 6 11 17 3 11 3 7
2024/2025559 31 96 36 40 119 24 21 16 3 16 22 135
2025/20261.184 98 56 79 55 140 81 132 66 313 103 34 27
2026/202758 24 34 0 0 0 0 0 0 0 0 0 0
Totale 4.080